Intelligent Bio Solutions Inc. (INBS) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Intelligent Bio Solutions Inc. (INBS) closed at USD 1.45 on 2026-10-14, a change of -85.6 % over the past year, with a market capitalization of USD 4.78M.

Intelligent Bio Solutions Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Intelligent Bio Solutions Inc. key figures

Previous close

USD 1.45 (2026-10-14)

1-year change

-85.6 %

Market cap

USD 4.78M

Enterprise value

USD 1.82M

P/E ratio (trailing)

-0.18

P/E ratio (forward)

4.11

EPS (trailing)

-7.98

EPS (forward)

0.35

PEG ratio

n/a

Price to book

0.76

Revenue growth

35.8 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.21

Employees

59

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Intelligent Bio Solutions Inc. and compare it with other stocks.